DLB
Dolby Laboratories
57.60$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.3% | 2.7% | 49.8% | 7.4% | 38.1% | 29.9% | 47.3% | 21.5% | 40.0% | 15.8% | 23.4% | 54.9% | 32.3% | |
| 8.3% | 6.6% | 5.7% | 7.3% | 8.0% | 7.1% | 6.6% | 7.7% | 8.0% | 7.7% | 6.8% | 8.2% | 7.6% | |
| 9.7% | 10.1% | 7.9% | 10.2% | 9.7% | 10.1% | 8.3% | 9.7% | 10.1% | 10.7% | 7.8% | 10.2% | 9.6% | |
| 15.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.8% | -32.3% | 9.8% | -18.1% | 3.8% | -3.6% | 9.1% | -8.1% | -4.0% | -16.3% | -18.2% | 29.7% | -3.7% | |
| 2.8% | 1.9% | 2.4% | 2.6% | 2.4% | 1.9% | 1.9% | 2.0% | 7.1% | 1.6% | 11.6% | 6.5% | 6.9% | |
| -6.8% | 0.2% | -4.9% | -2.7% | -85.7% | -2.3% | 7.0% | -2.0% | -7.1% | 0.4% | -11.6% | -3.2% | -5.7% | |
| 8.9% | 9.0% | 7.9% | 9.9% | 9.4% | 8.8% | 8.6% | 10.0% | 10.3% | 9.9% | 8.7% | 11.1% | 9.9% | |
| -9.5% | -36.3% | -7.3% | -12.6% | -7.1% | -13.3% | -9.9% | -13.1% | -12.1% | -29.2% | -16.4% | -21.6% | -19.9% | |
| -14.7% | -39.7% | -12.1% | -20.2% | -19.7% | -16.1% | -17.6% | -19.2% | -20.9% | -35.1% | -25.2% | -29.8% | -27.8% | |
| 6.5% | -34.6% | 31.7% | -15.8% | -65.9% | 9.5% | 37.5% | 2.0% | 12.0% | -19.0% | -13.6% | 21.3% | -1.3% | |
| 26.4% | 0.7% | 47.3% | 4.7% | 35.7% | 28.0% | 45.5% | 19.4% | 32.9% | 14.3% | 11.7% | 48.4% | 25.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.